← Back to Search

Wearable Robotic Orthosis

MyoMo for Spinal Cord Injury (MyoMo in SCI Trial)

N/A
Waitlist Available
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 10 weeks
Awards & highlights

Summary

This trial looks at whether the MyoPro device can help improve upper extremity function in people with incomplete spinal cord injury.

Eligible Conditions
  • Spinal Cord Injury

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 10 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 10 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Brain signals measurement
CUE-Q
GRASSP
+3 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: MyoProExperimental Treatment1 Intervention
Receiving MyoMo training in-clinic and at home for 6-weeks
Group II: ControlActive Control1 Intervention
Receiving conventional therapy/training in-clinic and using their prescribed static brace (or others) at home for 6-weeks
Group III: Myo-SBActive Control1 Intervention
Receiving MyoMo training in-clinic and using their prescribed static brace (or others) at home for 6-weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MyoMo
2019
N/A
~20

Find a Location

Who is running the clinical trial?

United States Department of DefenseFED
875 Previous Clinical Trials
329,971 Total Patients Enrolled
Kessler FoundationLead Sponsor
175 Previous Clinical Trials
10,743 Total Patients Enrolled

Media Library

Spinal Cord Injury Research Study Groups: MyoPro, Control, Myo-SB
Spinal Cord Injury Clinical Trial 2023: MyoPro Highlights & Side Effects. Trial Name: NCT04855812 — N/A
MyoPro (Wearable Robotic Orthosis) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04855812 — N/A
~3 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top